All entries for: Vir Biotechnology, Inc.

February 23, 2026

Vir Biotechnology, Inc.

Neutral Outlook

San Francisco, CA
201-500 employees

Among other things, the IRA contains many provisions aimed at reducing this financial burden on individuals by reducing the co-insurance and co-payment costs, expanding eligibility for lower income subsidy plans, and price caps on annual out-of-pocket expenses, each of which could have potential pricing and reporting implications.

Disease Area: Antiviral, Chronic Disease, Immune Diseases, Infectious Diseases, Oncology
Drug Type: Biologic
Scroll to Top